Vanguard Fiduciary Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$771M Buy
32,005,869
+4,610
+0% +$121K 0.17% 94
2026
Q1
$899M Buy
+32,001,259
New +$852M 0.23% 71

Other funds holding PFE

Vanguard Fiduciary Trust's PFE Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Pfizer (PFE) stake by 0.01% in Q2 2026, buying an estimated $121K and bringing the position to 32,005,869 shares worth $771M. The position accounts for 0.17% of the portfolio, ranked #94.

Vanguard Fiduciary Trust first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $899M in Q1 2026. 2,799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vanguard Fiduciary Trust held 32,005,869 shares of Pfizer worth $771M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 4,610 Pfizer shares in Q2 2026, an estimated $121K.
  • Pfizer made up 0.17% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #94 holding.
  • Vanguard Fiduciary Trust first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Pfizer position peaked at $899M in Q1 2026.
  • 2,799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.